Monitoring Breast Tumor Lung Metastasis by U-SPECT-II/CT with an Integrin αvβ3-Targeted Radiotracer 99mTc-3P-RGD2
Authors:
Open Access
- 1 January 2012
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 2 (6) , 577-588
Abstract
Purpose: The purpose of this study was to evaluate the capability of u-SPECT-II/CT to monitor the progression of breast cancer lung metastasis using 99mTc-3P-RGD2 as a radiotracer.Keywords
This publication has 39 references indexed in Scilit:
- Integrin Targeted Delivery of RadiotherapeuticsTheranostics, 2011
- Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECTTheranostics, 2011
- Mouse models for breast cancer metastasisBiochemical and Biophysical Research Communications, 2010
- In Vivo Nano-imaging of Membrane Dynamics in Metastatic Tumor Cells Using Quantum DotsJournal of Biological Chemistry, 2010
- Radiolabeled Cyclic RGD Peptides as Integrin αvβ3-Targeted Radiotracers: Maximizing Binding Affinity via BivalencyBioconjugate Chemistry, 2009
- Changes inHER2Expression in Breast Cancer Xenografts After Therapy Can Be Quantified Using PET and18F-Labeled Affibody MoleculesJournal of Nuclear Medicine, 2009
- Improving Tumor-Targeting Capability and Pharmacokinetics of 99mTc-Labeled Cyclic RGD Dimers with PEG4 LinkersMolecular Pharmaceutics, 2008
- Altered expression pattern of integrin alphavbeta3 correlates with actin cytoskeleton in primary cultures of human breast cancerCancer Cell International, 2007
- Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGDPLOS Medicine, 2005
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002